Minerva Neurosciences Inc.
NERV | NASDAQ
$3.79
+$0.11 (+2.99%)
Sep 22, 2026, 11:48 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -0.12 | 11.68 | -1.33 | -0.26 | -0.69 | 49.26 |
PEG Ratio | 0 | -0.11 | 0.06 | 0.01 | 0 | -0.48 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | 2.32 |
PB Ratio | -0.24 | -0.65 | -1.41 | -0.42 | 4.29 | 1.81 |
P/FCF Ratio | 0 | -0.86 | -2.71 | -0.34 | -1.39 | -2.82 |
P/OCF Ratio | 0 | -0.86 | -2.71 | -0.34 | -1.39 | -2.82 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | -82.14 |
Debt / Equity Ratio | -0.46 | n/a | n/a | n/a | n/a | 0 |
Quick Ratio | 36.29 | 7.85 | 12.57 | 29.15 | 22.07 | 8.68 |
Current Ratio | 36.29 | 7.85 | 12.57 | 29.15 | 22.07 | 8.68 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | 0.71 |
Interest Coverage | n/a | -4.79 | -2.79 | -3.41 | -7.17 | n/a |
Return on Equity | 208.47% | -5.60% | 105.44% | 160.35% | -625.73% | 3.69% |
Return on Assets | -299.51% | 3.87% | -52.73% | -58.29% | -64.71% | 3.37% |
Return on Invested Capital | -15.79% | -63.69% | -43.17% | -46.98% | -58.93% | 3.38% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | 100% |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | 4.71% |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | 4.71% |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | 4.49% |
FCF Margin | n/a | n/a | n/a | n/a | n/a | -82.14% |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | 5.14% |
Add to Watchlist
Select watchlists to add or remove NERV